Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ampio Pharmaceuticals Inc AMPE

Healthcare
Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.

Recent & Breaking News (OTCPK:AMPE)

Ampio Announces Very Positive Results of the Open Label Portion of the Multiple Intra-articular Injections Study of Ampion(TM) in Patients with Osteoarthritis of the Knee at Week Six of the Trial

PR Newswire August 18, 2014

Leading Small-Cap Stars Health Care Stock for August 18 Morning Session is Provectus Biopharmaceuticals Inc. (PVCT)

Equities.com August 18, 2014

Leading Health Care Stock for Small-Cap Stars is Insys Therapeutics Inc (INSY) for August 15

Equities.com August 15, 2014

Leading Small-Cap Stars Health Care Stock for August 15 Morning Session is Boston Therapeutics Inc (BTHE)

Equities.com August 15, 2014

Luoxis Broadens Global Research Network for RedoxSYS(TM) oxidation-reduction potential (ORP) diagnostic system; Announces 17 Studies Currently Underway and Additional 30 Studies Set to Begin in 2014

PR Newswire August 11, 2014

Ampio announces positive results on the open label portion of the Multiple injection Study of Ampion(TM) in patients with osteoarthritis of the knee.

PR Newswire August 5, 2014

Ampio Pharmaceuticals announces the FDA has issued a written response and accepted the Ampio plan for beginning production of Ampion(TM) in the new facility.

PR Newswire July 30, 2014

Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado

PR Newswire July 23, 2014

Ampio Initiates Study of Multiple Injections of Ampion(TM) Into the Knees of Patients with OA of the Knee to Assess its Healing and Cartilage Regeneration Effects

PR Newswire June 30, 2014

Ampio Pharmaceuticals, in Response to Positive Feedback, Closes Enrollment in the OptimEyes Study (Optina(TM)) and Will Present the Data to the FDA for Guidance

PR Newswire June 25, 2014

Ampio Pharmaceuticals Announces Appointment of Gregory A. Gould as Chief Financial Officer

PR Newswire June 5, 2014

Ampio Pharmaceuticals to present at the Jefferies 2014 Global Healthcare Conference on Tuesday, June 3rd at 8:30 AM

PR Newswire May 21, 2014

Luoxis Awarded Health Canada Approval for RedoxSYS(TM) Diagnostic System

PR Newswire April 22, 2014

Ampio Pharmaceuticals' Vyrix Files Registration Statement for Proposed Initial Public Offering

PR Newswire April 21, 2014

Ampio Pharmaceuticals' Vyrix Enters into an Agreement with Paladin Labs for Exclusive Rights to Zertane(TM) in Canada and Other Territories to Broaden its International Footprint

PR Newswire April 10, 2014

Results from the 20 weeks extension of the Ampion(TM) SPRING study to be presented at the Western Orthopedic Association Conference

PR Newswire April 9, 2014

Luoxis Obtains CE Marking for RedoxSYS(TM) Diagnostic System

PR Newswire April 2, 2014

Ampio Announces Investor call Thursday March 13, 4 PM EDT.

PR Newswire March 11, 2014

Ampio Pharmaceuticals, Inc. Closes Sale Of 9,775,000 Shares Of Common Stock

PR Newswire March 5, 2014

Ampio Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of 8,500,000 Shares Of Common Stock

PR Newswire February 27, 2014